A controlled
randomized treatment study: the effects of a cognitive remediation program on adolescents with early onset psychosis
Not exact matches
Besides
randomized controlled clinical trials, there are a number of ways researchers can
study how a particular cancer
treatment is playing out in the real world: there are retrospective
studies, observational
studies, and even prospective research done using patient registries.
For the same reason, it is not easy to prove
treatment efficacy by means of controlled,
randomized studies, the «gold standard» for evaluating new therapies.
In the only controlled,
randomized scientific
study to compare graduated extinction and «positive routines» head - to - head, there were no significant differences in
treatment outcomes for kids (Adams and Rickert 1989).
Livingston V and Stringer J: The
Treatment of Staphylococcus Aureus Infected Sore Nipples: A
Randomized Comparative
Study, J Human Lact 1999, 15 (3): 241 - 246.
Lactobacillus reuteri (American Type Culture Collection Strain 55730) versus simethicone in the
treatment of infantile colic: a prospective
randomized study.
In three
randomized trials,
treatment of chronic low back pain with radiofrequency denervation, a procedure that can be performed with different techniques including the application of an electric current to the pain - conducting nerve, resulted in either no improvement or no clinically important improvement in chronic low back pain, according to a
study published by JAMA.
However, prior to this
study there has been a lack of
randomized controlled trials with a long - term follow - up that compare the effectiveness of noninvasive
treatments.
The REACT (
Randomized Evaluation of an Algorithm for Crohn's
Treatment)
study, led by Robarts Clinical Trials at Western University (London, Canada) provides valuable new insights for community gastroenterologists which should benefit patients.
Since
randomized clinical trials — the gold - standard in research — don't accommodate patients» preferences, Zoellner and her research team used a
study design called a «doubly
randomized preference trial» to investigate whether giving patients a choice affects their
treatment outcomes.
Another problem is that modeling
studies, like this one, are inherently less powerful than other kinds of medical research:
randomized clinical trials, the gold standard in medical research, in which patients are randomly assigned different
treatments or no
treatment; case - control
studies, which compare patients who have a condition with those who do not; or cohort
studies, which determine the risk of contracting a disease by
studying a group of people with similar demographics.
The
study was a
randomized phase II trial testing whether the addition of local
treatment, in the form of consolidative radiation therapy, to the standard
treatment of systemic therapy improved progression - free survival for patients with limited metastatic NSCLC.
«This is the first
study to show that a systemic therapy provides significant clinical benefit in a
randomized fashion to advanced uveal melanoma patients, who have very limited
treatment options,» said Richard D. Carvajal, MD, a medical oncologist at Memorial Sloan - Kettering and lead author on the
study.
Dr. Bachhuber and coauthors conclude: «To fully understand the effect of medical cannabis on the use of other drugs, prospective longitudinal
studies randomizing patients to cannabis versus other
treatments are urgently needed.»
Women with a DCIS diagnosis who participate in the
study will be
randomized to receive one of two
treatment approaches: The current standard of care consisting of surgery and radiation therapy, or careful monitoring with mammograms and physical exams every six months.
A total of 63 currently depressed patients, diagnosed with either major depressive disorder or bipolar disorder, participated in the
study and were
randomized to receive a single 20 - minute
treatment of real LFMS or sham LFMS, where the device was on but the electromagnetic fields were inactive.
They were
randomized into three
treatment groups and received the assigned
study drug by injection into the eye until the DME resolved or stabilized.
After initial screening, the researchers
randomized the
study participants into three groups: a referral group that received a list of
treatment services; a brief intervention group that received a motivational consultation and referral; and a third group given a brief intervention and
treatment with buprenorphine that was continued in primary care.
Although the
study began as a
randomized trial that divided subjects into four
treatment groups (placebo, deprenyl, α - tocopherol, and deprenyl / α - tocopherol), this was terminated early because positive effects of deprenyl were observed and all subjects then received deprenyl for approximately 18 months.
An analysis of more than 600 class I (procedure /
treatment should be performed / administered) American College of Cardiology / American Heart Association guideline recommendations published or revised since 1998 finds that about 80 percent were retained at the time of the next guideline revision, and that recommendations not supported by multiple
randomized studies were more likely to be downgraded, reversed, or omitted, according to a
study in the May 28 issue of JAMA.
Contrary to the proclamations of many scientists, unreliable medical
study results do not disappear with large,
randomized controlled trials, in which subjects are randomly assigned to a
treatment or placebo group.
The first
study enrolled older adults diagnosed with late - life depression into a
treatment trial where they were
randomized to receive either a mobile, tablet - based
treatment technology developed by Akili Interactive Labs called Project: EVO or an in - person therapy technique known as problem - solving therapy (PST).
This
study was presented as the Late - Breaking Clinical Trial (Abstract 49403): The Surgical
Treatment of Moderate Ischemic Mitral Regurgitation: A
Randomized Clinical Trial From The Cardiothoracic Surgical Trials Network.
This
study was presented at the Featured Clinical Research Session I: Two - year Outcomes of Surgical
Treatment of Moderate Ischemic Mitral Regurgitation: A
Randomized Clinical Trial from The Cardiothoracic Surgical Trials Network The Moderate Ischemic Mitral Regurgitation trial was supported by a cooperative agreement (U01 HL088942) funded by the National Heart Lung and Blood Institute, the National Institutes of Neurological Disorders and Stroke of the National Institutes of Health (NIH), Bethesda, MD, and the Canadian Institutes of Health Research.
In the
randomized study, patients were assigned to receive either intravenous metoprolol or a placebo
treatment at the moment of diagnosis of a myocardial infarction during ambulance transit to the catheterization laboratory.
Similarly the epilepsy
studies, including a single
randomized trial, found that medical cannabis reduced the frequency of seizures in participants, some with
treatment - resistant seizures.
A systematic review of published
studies on the use of medical cannabis in children and adolescents finds a notable lack of
studies and a minimal number of the
randomized, controlled trials needed to confirm the effectiveness of a
treatment.
The original,
randomized, open label
study, which enrolled 20 outpatient men with cirrhosis and recurrent HE receiving standard - of - care (SOC)
treatment, had previously reported that a single FMT enema after antibiotic pretreatment improved cognitive function at Day 20 and reduced HE episodes and hospitalizations over the following 5 months compared with SOC.1 The long - term outcomes of this
study, which were presented today at The International Liver Congress ™ 2018 in Paris, France, demonstrated sustained and statistically significant reductions in the number of HE episodes and hospitalizations as well as improvements in cognitive function over 1 year in the men who received FMT compared with the control group.
Study participants (n = 146; 101 males, 45 females) were enrolled in a 16 - week
randomized clinical trial comparing naltrexone with placebo
treatment.
He also believes that additional research — possibly
randomized, prospective
studies — should be done to compare the safety and efficacy of PAE with other commonly performed BPH
treatments.
In the
randomized, blinded
study, half of the participants received the
treatment while half received a placebo.
In the double - blind,
randomized crossover
study, every patient had the opportunity to try every one of the three
treatments: the combination, morphine alone and nortriptyline alone in each of the three six - week
treatment periods.
A large - scale
randomized clinical
study is needed to confirm the therapeutic value of video - game
treatment in clinical situations.
A Phase 3 Open - Label
Randomized Study of Quizartinib (AC220) Monotherapy Versus Salvage Chemotherapy in Subjects with FLT3 - ITD Positive Acute Myeloid Leukemia (AML) Refractory To or Relapsed After First - line
Treatment With or Without Hematopoietic Stem Cell Transplantation (HSCT) Consolidation
14255: STAT3 Signaling During Chemo - Radiation for Squamous Cell Carcinoma of the Head and Neck 14340: A Phase II,
Randomized, Open - Label, Multi-Center, Global
Study of MEDI4736 Monotherapy, Tremelimumab Monotherapy, and MEDI4736 in Combination with Tremelimumab in Patients with Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck (SCCHN) 14258:
Randomized Phase II and Phase III
Studies of Individualized
Treatment for Nasopharyngeal Carcinoma Based on Biomarker Epstein Barr Virus (EBV) Deoxyribonucleic Acid (DNA)
A Phase III, Open Label,
Randomized Study to Assess the Efficacy and Safety of Olaparib (Lynparza) versus Enzalutamide or Abiraterone Acetate in Men with Metastatic Castration - Resistant Prostate Cancer who have Failed Prior
Treatment with a New Hormonal Agent and have Homologous Recombination Repair Gene Mutations.
Of special note today: gut microbiota species expressing orthologs of human Ro60 might be involved in triggering and sustaining chronic autoimmunity in lupus; The portal vein blood microbiome in patients with liver cirrhosis; A
randomized clinical
study suggests dietary promotion of short chain fatty acid producing gut microbes as an effective
treatment for type 2 diabetes; and the sexual dimorphism of root, flower and leaf microbiomes in the wild strawberry plant
A Phase 3, Multicenter,
Randomized, Open - Label
Study of Guadecitabine (SGI - 110) versus
Treatment Choice in Adults with Previously Treated Acute Myeloid Leukemia
Study Selection
Randomized placebo - controlled trials of antidepressants approved by the Food and Drug Administration in the
treatment of major or minor depressive disorder were selected.
Data were obtained from 17
randomized studies of rTMS for AVH; 5
studies fulfilled the criteria for the meta - analysis on the effect of rTMS 1 month after the end of
treatment.
In a
randomized, double - blind, sham - controlled
study, Benninger and colleagues (2011) examined the safety and effectiveness of intermittent theta - burst stimulation (iTBS) in the
treatment of motor symptoms in Parkinson disease (PD); iTBS of the motor and DLPFC was investigated in 8 sessions over 2 weeks.
[35] The first
randomized, controlled
study of DBS for the
treatment of TRD targeting the ventral capsule / ventral striatum area did not demonstrate a significant difference in response rates between the active and sham groups at the end of a 16 - week
study.
Methods: In a multicenter,
randomized, patient - and rater - blind, controlled, parallel - group, phase II
study, 42 AD patients were assigned (1: 1) to PE
treatment or control (sham) groups.
The U.S. drug maker released a statement on Monday saying that its Keynote - 010
study, a
randomized Phase two - third trial, showed that patients who were taking two different doses of Keytruda (FDA - approved two mg / kg dose and
treatment dose of 10 mg / kg given every three weeks) had longer survival compared to those who took docetaxel, the drug widely used for non-small cell lung cancer (NSCLC).
The drug, a monoclonal antibody called ipilimumab, is the first
treatment of any kind ever shown in a large,
randomized phase III clinical
study (
study MDX010 - 20) to improve overall survival in patients with metastatic melanoma who no longer respond to standard therapy.
The expert review panel recommended one practice guideline based on a 2005
randomized trial that provided data to support a memory retraining protocol.12, 13 The trial enrolled 29 subjects with MS - related learning deficits and
randomized them to either the control group (n = 14) or the experimental group (n = 15).13 Both groups participated in 8 «
treatment» sessions, which consisted of nontraining memory tasks for the control group and the Story Memory Technique (SMT), which taught the skills of visualization and context to improve learning, for the experimental group.13 In subjects with moderately severe impairment, 88 % in the experimental group showed significant improvement in learning abilities compared with 38 % in the control group (P <.01).13 Subjects with mild impairment showed little improvement.13 On this basis, the technique used in this
study was recommended by the review panel as a practice guideline for the rehabilitation of learning and memory in persons with MS. 12
According to the researchers, there have been proposals that vitamin C dosages should be more than 15 g / day for the best
treatment of colds, but the highest dosages that have so far been looked at in
randomized studies have been much lower.
The 2012
Treatment Options for Type 2 Diabetes in Adolescents and Youths (TODAY)
randomized study reduced caloric intake to a miniscule 1200 - 1500 calories per day of a low - fat diet.
A systematic review of 17,
randomized controlled trials found 11
studies that linked regular yoga practice to significantly greater reductions in systolic BP compared to pharmacotherapy, breath awareness, health education, no
treatment, or usual care.
One
randomized double blind comparison
study assessed the effectiveness of two different ointments containing witch hazel in the
treatment of 22 patients with moderate or severe eczema.